Free Trial
NASDAQ:SOPH

SOPHiA GENETICS (SOPH) Stock Price, News & Analysis

SOPHiA GENETICS logo
$3.31 +0.05 (+1.53%)
(As of 05:27 PM ET)

About SOPHiA GENETICS Stock (NASDAQ:SOPH)

Key Stats

Today's Range
$3.23
$3.31
50-Day Range
$3.10
$3.99
52-Week Range
$2.70
$7.37
Volume
35,622 shs
Average Volume
62,433 shs
Market Capitalization
$216.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.40
Consensus Rating
Moderate Buy

Company Overview

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

SOPHiA GENETICS Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
49th Percentile Overall Score

SOPH MarketRank™: 

SOPHiA GENETICS scored higher than 49% of companies evaluated by MarketBeat, and ranked 570th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    SOPHiA GENETICS has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    SOPHiA GENETICS has only been the subject of 1 research reports in the past 90 days.

  • Read more about SOPHiA GENETICS's stock forecast and price target.
  • Earnings Growth

    Earnings for SOPHiA GENETICS are expected to grow in the coming year, from ($0.98) to ($0.81) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of SOPHiA GENETICS is -3.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of SOPHiA GENETICS is -3.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    SOPHiA GENETICS has a P/B Ratio of 1.05. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.06% of the float of SOPHiA GENETICS has been sold short.
  • Short Interest Ratio / Days to Cover

    SOPHiA GENETICS has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in SOPHiA GENETICS has recently decreased by 52.74%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    SOPHiA GENETICS does not currently pay a dividend.

  • Dividend Growth

    SOPHiA GENETICS does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.06% of the float of SOPHiA GENETICS has been sold short.
  • Short Interest Ratio / Days to Cover

    SOPHiA GENETICS has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in SOPHiA GENETICS has recently decreased by 52.74%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    SOPHiA GENETICS has a news sentiment score of 0.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for SOPHiA GENETICS this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, SOPHiA GENETICS insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.88% of the stock of SOPHiA GENETICS is held by insiders.

  • Percentage Held by Institutions

    Only 31.59% of the stock of SOPHiA GENETICS is held by institutions.

  • Read more about SOPHiA GENETICS's insider trading history.
Receive SOPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SOPHiA GENETICS and its competitors with MarketBeat's FREE daily newsletter.

SOPH Stock News Headlines

Why I'm telling friends to avoid gold stocks
Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."
Craig-Hallum bullish on Sophia Genetics, initiates with a Buy
SOPHiA GENETICS (SOPH) Receives a Buy from RBC Capital
Morgan Stanley Sticks to Its Hold Rating for SOPHiA GENETICS (SOPH)
See More Headlines

SOPH Stock Analysis - Frequently Asked Questions

SOPHiA GENETICS's stock was trading at $4.71 at the start of the year. Since then, SOPH stock has decreased by 29.7% and is now trading at $3.31.
View the best growth stocks for 2024 here
.

SOPHiA GENETICS SA (NASDAQ:SOPH) released its earnings results on Tuesday, November, 5th. The company reported ($0.28) EPS for the quarter, missing analysts' consensus estimates of ($0.24) by $0.04. The firm earned $15.85 million during the quarter, compared to the consensus estimate of $15.90 million. SOPHiA GENETICS had a negative net margin of 110.71% and a negative trailing twelve-month return on equity of 55.06%.

SOPHiA GENETICS (SOPH) raised $234 million in an initial public offering (IPO) on Friday, July 23rd 2021. The company issued 13,000,000 shares at $17.00-$19.00 per share.

SOPHiA GENETICS's top institutional shareholders include Principal Financial Group Inc. (2.23%), Principal Financial Group Inc. (2.23%), Moloney Securities Asset Management LLC (0.12%) and Green Alpha Advisors LLC (0.03%).

Shares of SOPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that SOPHiA GENETICS investors own include Occidental Petroleum (OXY), PayPal (PYPL), Chesapeake Energy (CHK), Cheniere Energy (LNG), Rocket Pharmaceuticals (RCKT), AbCellera Biologics (ABCL) and Farmers & Merchants Bancorp (FMAO).

Company Calendar

Last Earnings
11/05/2024
Today
12/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SOPH
Fax
N/A
Employees
520
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$7.40
High Stock Price Target
$11.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+126.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Net Income
$-78,980,000.00
Net Margins
-110.71%
Pretax Margin
-109.76%

Debt

Sales & Book Value

Annual Sales
$64.49 million
Book Value
$3.16 per share

Miscellaneous

Free Float
62,185,000
Market Cap
$213.78 million
Optionable
Not Optionable
Beta
0.99
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

This page (NASDAQ:SOPH) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners